Laminar, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Laminar, Inc. - overview
Established
2019
Location
Santa Rosa, CA, US
Primary Industry
Medical Devices & Equipment
About
Based in Santa Rosa, US, and founded in 2019, Laminar, Inc. is a MedTech company that engages in the development of medical devices intended for use in LAA (Left Atrial Appendage) closure procedures. As of February 2024, the company is being led by Randy Lashinski, as its President and Chief Executive Officer. In November 2023, Johnson & Johnson, Inc.
acquired Laminar, Inc. from Santé Ventures for USD 400 million. Laminar, Inc. focuses on the development of a catheter-based Left Atrial Appendage (LAA) closure device.
The company's product is used by surgeons to seal off the left atrial appendage in patients with atrial fibrillation. The device prevents blood from reaching that location, lowering the risk of a thromboembolic stroke.
Current Investors
Sante Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices
Website
www.laminarlaa.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.